ATE490972T1 - Biologisch aktive peptide und deren verwendung zur reparatur verletzter nerven - Google Patents
Biologisch aktive peptide und deren verwendung zur reparatur verletzter nervenInfo
- Publication number
- ATE490972T1 ATE490972T1 AT02770017T AT02770017T ATE490972T1 AT E490972 T1 ATE490972 T1 AT E490972T1 AT 02770017 T AT02770017 T AT 02770017T AT 02770017 T AT02770017 T AT 02770017T AT E490972 T1 ATE490972 T1 AT E490972T1
- Authority
- AT
- Austria
- Prior art keywords
- biologically active
- active peptides
- injured nerves
- laminin
- repairing injured
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 210000005036 nerve Anatomy 0.000 title 1
- 108010057670 laminin 1 Proteins 0.000 abstract 2
- 230000001537 neural effect Effects 0.000 abstract 2
- 210000002241 neurite Anatomy 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000008929 regeneration Effects 0.000 abstract 1
- 238000011069 regeneration method Methods 0.000 abstract 1
- 208000020431 spinal cord injury Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20012082A FI20012082A0 (fi) | 2001-10-26 | 2001-10-26 | Biologisesti aktiiviset peptidit hermovauroiden korjaamiseksi |
| PCT/FI2002/000831 WO2003035675A1 (en) | 2001-10-26 | 2002-10-25 | Biologically active peptides and their use for repairing injured nerves |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE490972T1 true ATE490972T1 (de) | 2010-12-15 |
Family
ID=8562134
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02770017T ATE490972T1 (de) | 2001-10-26 | 2002-10-25 | Biologisch aktive peptide und deren verwendung zur reparatur verletzter nerven |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20040266991A1 (https=) |
| EP (1) | EP1438329B1 (https=) |
| JP (1) | JP4312054B2 (https=) |
| AT (1) | ATE490972T1 (https=) |
| AU (1) | AU2002336124B2 (https=) |
| CA (1) | CA2465245C (https=) |
| DE (1) | DE60238551D1 (https=) |
| DK (1) | DK1438329T3 (https=) |
| FI (1) | FI20012082A0 (https=) |
| WO (1) | WO2003035675A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005029468A1 (de) * | 2005-06-24 | 2006-12-28 | Plt Patent & Licence Trading Ltd. | Verwendung von Inhibitoren der N-Methyltransferasen in der Therapie des Parkinson-Syndroms |
| RU2301678C1 (ru) | 2006-05-30 | 2007-06-27 | Общество С Ограниченной Ответственностью "Сиа Пептайдс" | Пептид, стимулирующий регенерацию нейронов центральной нервной системы, фармацевтическая композиция на его основе и способ ее применения |
| CN101784869A (zh) * | 2007-05-31 | 2010-07-21 | 赫兹公司 | 为归还租赁车辆的旅客自动生成航班登机牌的系统和方法 |
| US8008253B2 (en) * | 2007-07-03 | 2011-08-30 | Andrew Tasker | Treatment for anxiety |
| US20090247466A1 (en) * | 2008-03-10 | 2009-10-01 | University Of Louisville Research Foundation | Neuroprotective integrin-binding peptide and angiopoietin-1 treatments |
| GB201700529D0 (en) | 2017-01-12 | 2017-03-01 | Rogers April | Laminin receptor peptide |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT276041B (de) * | 1968-08-16 | 1969-11-10 | Dragoco Gerberding Co Gmbh | Verfahren zur Herstellung eines konzentrierten, praktisch sterilen Rohzwiebelaromas |
| US3590722A (en) * | 1969-06-09 | 1971-07-06 | Samuel Leptrone | Flavor injector device |
| HU185263B (en) | 1981-06-12 | 1984-12-28 | Richter Gedeon Vegyeszet | Process for producing peptides effective on the immuncontroll analogous with the tp5 |
| FI922517L (fi) * | 1992-05-29 | 1993-11-30 | Paeivi Liesi | Nervrepareringsmedel och dess anvaendning |
| GB9217316D0 (en) | 1992-08-14 | 1992-09-30 | Ludwig Inst Cancer Res | Schwann cell mitogenic factor,its preparation and use |
| GB9324473D0 (en) | 1993-11-29 | 1994-01-12 | Oxford Res Support Co Ltd | Isolation of streptokinase by affinity chromatography |
| AU710838B2 (en) * | 1995-07-26 | 1999-09-30 | Firmenich S.A. | Flavoured products and a process for their preparation |
| US5721256A (en) * | 1997-02-12 | 1998-02-24 | Gpi Nil Holdings, Inc. | Method of using neurotrophic sulfonamide compounds |
| DE19882746T1 (de) | 1997-04-03 | 2001-10-18 | California Inst Of Techn | Enzymvermittelte Modifikation von Fibrin für das Gewebs-Engineering |
| US20020168718A1 (en) * | 1997-04-03 | 2002-11-14 | California Institute Of Technology | Enzyme-mediated modification of fibrin for tissue engineering |
| US6075119A (en) * | 1997-04-07 | 2000-06-13 | The Rockefeller University | Peptides useful for reducing symptoms of toxic shock syndrome |
| IL121191A0 (en) * | 1997-06-29 | 1997-11-20 | Yeda Res & Dev | Synthetic peptides and pharmaceutical compositions comprising them |
| MXPA01010692A (es) | 1999-04-22 | 2004-09-06 | Univ Zuerich | Matrices de proteina modificadas para ingenieria de tejidos o liberacion controlada. |
| DE20010297U1 (de) | 2000-06-08 | 2000-08-31 | ETH Zürich, Zürich | Enzymvermittelte Modifizierung von Fibrin zur Gewebemanipulation: Fibrin-Formulierungen mit Peptiden |
-
2001
- 2001-10-26 FI FI20012082A patent/FI20012082A0/fi unknown
-
2002
- 2002-10-25 US US10/492,850 patent/US20040266991A1/en not_active Abandoned
- 2002-10-25 WO PCT/FI2002/000831 patent/WO2003035675A1/en not_active Ceased
- 2002-10-25 DE DE60238551T patent/DE60238551D1/de not_active Expired - Lifetime
- 2002-10-25 EP EP02770017A patent/EP1438329B1/en not_active Expired - Lifetime
- 2002-10-25 AU AU2002336124A patent/AU2002336124B2/en not_active Ceased
- 2002-10-25 DK DK02770017.8T patent/DK1438329T3/da active
- 2002-10-25 AT AT02770017T patent/ATE490972T1/de not_active IP Right Cessation
- 2002-10-25 CA CA2465245A patent/CA2465245C/en not_active Expired - Fee Related
- 2002-10-25 JP JP2003538188A patent/JP4312054B2/ja not_active Expired - Fee Related
-
2005
- 2005-05-12 US US11/127,206 patent/US7659255B2/en not_active Expired - Fee Related
-
2008
- 2008-06-18 US US12/141,129 patent/US7741436B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20040266991A1 (en) | 2004-12-30 |
| JP4312054B2 (ja) | 2009-08-12 |
| US7741436B2 (en) | 2010-06-22 |
| FI20012082A0 (fi) | 2001-10-26 |
| US7659255B2 (en) | 2010-02-09 |
| JP2005512979A (ja) | 2005-05-12 |
| AU2002336124B2 (en) | 2008-07-03 |
| CA2465245A1 (en) | 2003-05-01 |
| CA2465245C (en) | 2012-09-11 |
| US20080249021A1 (en) | 2008-10-09 |
| DK1438329T3 (da) | 2011-03-28 |
| DE60238551D1 (de) | 2011-01-20 |
| EP1438329A1 (en) | 2004-07-21 |
| US20050288231A1 (en) | 2005-12-29 |
| WO2003035675A1 (en) | 2003-05-01 |
| EP1438329B1 (en) | 2010-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE314860T1 (de) | Verwendung des copolymer-1 peptids sowie von damit verwandten peptiden und polypeptiden und von damit behandelten t-zellen zur neuroprotektion vor glutamattoxizitaet | |
| CY1111120T1 (el) | Πεπτιδια που παραγονται απο πρωτεϊνες νευρικων ινων και η ιατρικη τους χρηση | |
| EP0693928A4 (en) | Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue | |
| IL161591A0 (en) | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells | |
| DE69841030D1 (de) | Apolipoprotein A-I Agonisten und deren Verwendung zur Behandlung dyslipidämischer Erkrankungen | |
| DE69938507D1 (en) | Fragment des "connective tissue growth factor" (ctgf) | |
| ATE353914T1 (de) | Peptide zur behandlung von tumoren und anderen bedingungen die die entfernung oder zerstörung von zelle erfordern | |
| MXPA02006885A (es) | Bloqueo del crecimiento axonal mediado por receptor de nogo. | |
| ATE410441T1 (de) | Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidinanalogen | |
| ATE285224T1 (de) | Methode zur prävention und behandlung von dehnungsstreifen (striae distensae) und deren verwendung in dermatologie | |
| DE60331546D1 (de) | Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung | |
| ATE490972T1 (de) | Biologisch aktive peptide und deren verwendung zur reparatur verletzter nerven | |
| DE69821793D1 (de) | Neuronale verwendungen des bmp-11 | |
| ATE408685T1 (de) | Antimikrobielle peptide, abstammend von ubiquicidin | |
| ATE193305T1 (de) | Osteogene wachstums-oligopeptide und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE356145T1 (de) | Polypeptide zur regenerierung des nervensystems | |
| DE60234843D1 (de) | Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten | |
| EP0917535A4 (en) | NEURO-ACTIVE PEPTIDE | |
| WO1999062931A3 (en) | A cell density signal protein suitable for treatment of connective tissue injuries and defects | |
| EP1714979A3 (en) | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells | |
| DE60221718D1 (de) | Eine, ein peptid und ein pigment enthaltende zusammensetzung und deren verwendung zur hautbräunung | |
| EP1847550A3 (en) | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells | |
| MX9800686A (es) | Nueva proteina hmw humana mp52s. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |